vTv Therapeutics (VTVT) Prepaid Assets (2014 - 2026)
vTv Therapeutics' (VTVT) quarterly Prepaid Assets came in at $521000.0 in Q1 2026, up 353.04% year-on-year from $115000.0 in Q1 2025, and down 29.88% quarter-over-quarter from $743000.0 in Q4 2025.
vTv Therapeutics (VTVT) Prepaid Assets (2014 - 2026) Analysis & Trends
vTv Therapeutics has disclosed Prepaid Assets across 13 years of filings, most recently posting $521000.0 for Q1 2026.
- Prepaid Assets for Q1 2026 came in at $521000.0, up 353.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $521000.0 (up 353.04% YoY), and the FY2025 annual result was $743000.0, up 324.57% from the prior year.
- Prepaid Assets came in at $521000.0 for Q1 2026 at vTv Therapeutics, down from $743000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $2.5 million in Q4 2022 to a low of $93000.0 in Q2 2025.
- The 5-year median for Prepaid Assets is $743000.0 (2025), against an average of $919235.3.
- Across the five-year window, Prepaid Assets sank 89.43% in 2025 and jumped 353.04% in 2026, its largest moves.
- vTv Therapeutics' Prepaid Assets stood at $2.5 million in 2022, then plunged by 58.85% to $1.0 million in 2023, then tumbled by 83.24% to $175000.0 in 2024, then jumped by 324.57% to $743000.0 in 2025, then declined by 29.88% to $521000.0 in 2026.
- The last three Prepaid Assets figures came in at $521000.0 (Q1 2026), $743000.0 (Q4 2025), and $112000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | vTv Therapeutics | 426.76 Mn | 426.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 521,000.00 |
| Dec 31, 2025 | 743,000.00 |
| Sep 30, 2025 | 112,000.00 |
| Jun 30, 2025 | 93,000.00 |
| Mar 31, 2025 | 115,000.00 |
| Dec 31, 2024 | 175,000.00 |
| Sep 30, 2024 | 1.06 Mn |
| Jun 30, 2024 | 303,000.00 |
| Mar 31, 2024 | 571,000.00 |
| Dec 31, 2023 | 1.04 Mn |
| Sep 30, 2023 | 1.87 Mn |
| Jun 30, 2023 | 1.32 Mn |
| Mar 31, 2023 | 1.85 Mn |
| Dec 31, 2022 | 2.54 Mn |
| Sep 30, 2022 | 1.28 Mn |
| Jun 30, 2022 | 643,000.00 |
| Mar 31, 2022 | 1.39 Mn |
| Dec 31, 2021 | 2.05 Mn |
| Sep 30, 2021 | 1.57 Mn |
| Jun 30, 2021 | 313,000.00 |